Imunon (IMNN) vs Silo Pharma (SILO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Silo Pharma is the larger company by market cap ($3.7 million vs $3.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IMNN | SILO |
|---|---|---|
| Share price | $0.5355 | $1.71 |
| Market cap | $3.47M | $3.69M |
| 1-day change | -5.22% | -9.04% |
| EPS (TTM) | $-3.31 | $-2.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $72.10K |
| Revenue growth (YoY) | — | 0.00% |
| Net income (latest FY) | $-14.50M | $-4.23M |
| Gross margin | — | 38.57% |
| Operating margin | — | -5936.95% |
| Net margin | — | -5863.50% |
| 52-week high | $4.35 | $10.43 |
| 52-week low | $0.50 | $1.10 |
| Distance from 52-week high | -87.69% | -83.60% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +3074.60% | — |
| Average volume | 150.49K | 65.47K |
| Shares outstanding | 6.49M | 2.16M |
| Employees | 20 | 3 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Imunon
IMNN stock →Imunon, Inc., a clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines in the United States. The company's lead clinical program is IMNN-001, a DNA-based immunotherapy that is in a Phase 3 clinical trial for the localized treatment of advanced ovarian cancer, as well as in the IND-enabling phase for colorectal and pancreatic cancers, and in the discovery phase for glioblastoma.
Health Care · Biotechnology: Pharmaceutical Preparations · 20 employees
About Silo Pharma
SILO stock →Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company.
Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees
IMNN vs SILO FAQ
Which is bigger, Imunon or Silo Pharma?
Silo Pharma (SILO) is larger, with a market capitalization of $3.69M compared with $3.47M for Imunon (IMNN).
Are Imunon and Silo Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.